» Articles » PMID: 19111879

Hypoxia-induced Lysyl Oxidase is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2008 Dec 30
PMID 19111879
Citations 643
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor cell metastasis is facilitated by "premetastatic niches" formed in destination organs by invading bone marrow-derived cells (BMDCs). Lysyl oxidase (LOX) is critical for premetastatic niche formation. LOX secreted by hypoxic breast tumor cells accumulates at premetastatic sites, crosslinks collagen IV in the basement membrane, and is essential for CD11b+ myeloid cell recruitment. CD11b+ cells adhere to crosslinked collagen IV and produce matrix metalloproteinase-2, which cleaves collagen, enhancing the invasion and recruitment of BMDCs and metastasizing tumor cells. LOX inhibition prevents CD11b+ cell recruitment and metastatic growth. CD11b+ cells and LOX also colocalize in biopsies of human metastases. Our findings demonstrate a critical role for LOX in premetastatic niche formation and support targeting LOX for the treatment and prevention of metastatic disease.

Citing Articles

Mechanical forces in the tumor microenvironment: roles, pathways, and therapeutic approaches.

Zhang Y, Fu Q, Sun W, Yue Q, He P, Niu D J Transl Med. 2025; 23(1):313.

PMID: 40075523 PMC: 11899831. DOI: 10.1186/s12967-025-06306-8.


A glucose-enriched lung pre-metastatic niche triggered by matrix stiffness-tuned exosomal miRNAs in hepatocellular carcinoma.

Zhao Y, Yu H, Li J, Qian J, Li M, Zhang X Nat Commun. 2025; 16(1):1736.

PMID: 39966385 PMC: 11836368. DOI: 10.1038/s41467-025-56878-8.


Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma.

Pham D, Hsu T J Biomed Sci. 2025; 32(1):17.

PMID: 39920694 PMC: 11806631. DOI: 10.1186/s12929-024-01111-9.


Immune Microenvironment in Breast Cancer Metastasis.

Qian B, Ma R Adv Exp Med Biol. 2025; 1464():413-432.

PMID: 39821036 DOI: 10.1007/978-3-031-70875-6_20.


Targeting Matrix Metalloproteinases and Their Inhibitors in Melanoma.

Szczygielski O, Dabrowska E, Niemyjska S, Przylipiak A, Zajkowska M Int J Mol Sci. 2025; 25(24.

PMID: 39769318 PMC: 11676509. DOI: 10.3390/ijms252413558.


References
1.
Kagan H, Li W . Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem. 2003; 88(4):660-72. DOI: 10.1002/jcb.10413. View

2.
Ahn G, Brown J . Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell. 2008; 13(3):193-205. PMC: 2967441. DOI: 10.1016/j.ccr.2007.11.032. View

3.
Cameron J, Skubitz A, Furcht L . Type IV collagen and corneal epithelial adhesion and migration. Effects of type IV collagen fragments and synthetic peptides on rabbit corneal epithelial cell adhesion and migration in vitro. Invest Ophthalmol Vis Sci. 1991; 32(10):2766-73. View

4.
Du R, Lu K, Petritsch C, Liu P, Ganss R, Passegue E . HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 2008; 13(3):206-20. PMC: 2643426. DOI: 10.1016/j.ccr.2008.01.034. View

5.
Condeelis J, Pollard J . Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006; 124(2):263-6. DOI: 10.1016/j.cell.2006.01.007. View